Kingswood Wealth Advisors LLC Grows Holdings in Cigna Group $CI

Kingswood Wealth Advisors LLC lifted its holdings in Cigna Group (NYSE:CI) by 5.3% during the second quarter, Holdings Channel reports. The institutional investor owned 5,498 shares of the health services provider’s stock after acquiring an additional 276 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in Cigna Group were worth $1,818,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CI. Valeo Financial Advisors LLC grew its position in shares of Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after buying an additional 3,471,249 shares during the period. Nuveen LLC purchased a new stake in shares of Cigna Group in the 1st quarter worth about $727,905,000. Price T Rowe Associates Inc. MD grew its position in Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares during the last quarter. GQG Partners LLC grew its position in Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its position in Cigna Group by 38.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after purchasing an additional 457,052 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts have issued reports on CI shares. Truist Financial set a $375.00 target price on shares of Cigna Group in a research note on Tuesday, September 2nd. TD Cowen upgraded shares of Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday, October 3rd. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on shares of Cigna Group and gave the stock a “buy” rating in a research note on Tuesday, August 5th. Finally, Guggenheim reiterated a “buy” rating and issued a $350.00 price objective (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $372.69.

Cigna Group Trading Up 1.4%

CI stock opened at $307.21 on Wednesday. The firm has a market cap of $82.00 billion, a PE ratio of 16.77, a price-to-earnings-growth ratio of 0.89 and a beta of 0.45. The firm has a fifty day moving average price of $292.94 and a 200 day moving average price of $309.54. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $358.88. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The company had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group’s revenue was up 11.0% on a year-over-year basis. During the same period last year, the company earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were given a $1.51 dividend. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.